Lv3
318 积分 2024-03-29 加入
Nonclinical Development of Next-generation Site-specific HER2-targeting Antibody–drug Conjugate (ARX788) for Breast Cancer Treatment
8小时前
待确认
Drug-Linkers in Antibody–Drug Conjugates: Perspective on Current Industry Practices
9天前
已完结
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
1个月前
已完结
Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial
2个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
2个月前
已完结
The evolving landscape of targets for lipid lowering: from molecular mechanisms to translational implications
2个月前
已完结
Antibody–Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
2个月前
已完结
Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody–drug Conjugate Targeting ADAM9-expressing Tumors
2个月前
已完结
The emerging role of galectins in cardiovascular disease
3个月前
已完结
The liver X receptor gene team: Potential new players in atherosclerosis
3个月前
已完结
皖公网安备34019202002308
